Member Info for alfista

I suppose the point that has never been quantified is what the scale of return can be for Fruitflow. perhaps someone who does now is slowly building a holding here. The size and frequency of trading has stepped up nicely. As you say Krusty, Blue is the colour, does wonders for the old portfolio.

That's an impressive China market knowledge from you lately Doc, good work

I think that's the most important aspect Dr H, whether the financial outcome of increased and more frequent production is to be financed by other means than a share based funding call. If we understand the update, we won't be asked to dilute. In which case, IMVHO, the future increased volumes will represent nothing but good news for holders. The sp appreciation since the update suggests that the market reads it this way.

Ahh, the bloke who insists he never reads my posts.

Yes, the profit I am seeing is not that great, yet, but it's already more than I'd have got in interest.

Do forgive me for trying to understand the market, how silly of me. I should have sold at a loss, and spent my day bickering

It'd be good to see a view from someone who has access to L2. We're seeing a much more liquid market being made since the last update, and seeing repeat orders for modest amounts leads me to wonder what size of buy is normally available, also what maximum will the MM's take. The mood of positivity is great to see,

In my experience of getting things made, it often becomes much easier as production volumes and frequency increase. Clearly, the production last time was the first that Provexis was fully responsible for, DSM had not reordered for a considerable time, staffing had changed at the producer. Also, did the producer doubt ability to pay, were they negotiating a risk management intermediary? Compare that to the proposed future. Much bigger volumes, more frequent production, expanded turnover and profitability for all involved. Again, from experience, that does tend to concentrate minds.

I agree, it's another stage of the long term PR work they've been doing in preparation.

Timing is a bit odd though, as their New Year hols kick off right about now. Kung hee fat choi to all at ByHealth, may this be the year of the smoother bloodflow !

It's all evidence that we hope is being put in front of the right people, but quite how a double blind trial could be conducted is hard to imagine.

The benefits of smoother bloodflow would surely show on all human function.

Keep in mind their New Year holidays.

The growth is pretty much inflation, costs also rising. If the chancellor is determined to see a sharp rise in business rates, that represents a huge cost. Also, their only national direct competitor has gone through the mill in the last period, all other retailer have benefitted from that weakness.

If staff are not being properly remunerated, that's not good.

Not really, more like very patient accumulation. Are they having to wait on sells?

Some signs of appetite, although no massive volume. I said a while ago that anyone who was seeking a holding would have to be prepared to pay, as there was little sign of current holders being willing to part with their shares. Breaking the 1.00 level would be a welcome sign.

It'll do more than that for those who chose to buy low rather than buy high and sell low bluey

Each move higher will prove that chump trading and endless whining isn't profitable.

That's a bit of an over simplification Bern.

It may be possible to play the cashflow in a positive way, where the payment terms to the manufacturer are longer than the payment terms for incoming cash. That does happen in many industries, and would be one explanation for the lack of cash calls. The next period may give further clarity, in the meantime the standard wording remains that a further fund raising could ne necessary. If we can lose that clause, and become cash positive, happy days.

We've been watching the super slow advance of By Health's regulatory journey for so long, it's a bit surreal to imagine that it is now imminent.

The Bid has jogged up nicely on almost no volume. If anyone is seeking to build a new position, I believe that they would have to plan to pay quite a lot more than current levels. Current holders have demonstrated an unwillingness to let their shares go.

A Merry Christmas to all on this board, and here's to a prosperous New Year

Not really. The investment is in the commercialisation of a novel discovery, Provexis being the IP owner.

Do as you please, your risk, but don't play the old multibagger guff or you'll get a response. Simple as that really.

They've gained from the demise of several others in the past few years, the market continues to adjust to a new trading pattern, and their major shareholder is not wrong in urging them to do more online. But that ain't easy, that space requires deep pockets to get traction. We shall see.

Rampy McRampface aren't you Zanab. Topps penetration in the new house builder market is minimal, Fact.

They do seem to know the timescales, given that it is a new process.

We live in hope.

Again, seriously, did you actually read the last report?

You make a highly sarcastic comment based on the loop tape you work with, then deny it is sarcasm.

I'm not clapping anyone, just stating facts, that being the the last period has been exceptional in the number of variables introduced. It's barely five minutes since the company took on the role of handling Fruitflow sales worldwide. We all hoped DSM would have done a better (quicker) job, but they haven't given up by any means, although their innovation of their Fruitflow application is still firmly in the future. Existing brands using Fruitflow, given modest sales growth, could create breakeven financially. We all know that ByHealth represents the step change we seek, and that is not in our hands. No amount of immature sniping will change the facts